Found 4 matching trials
Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
PHASE2This is a study to determine the safety and tolerability of 28 days of dail...
Location
Multiple Locations
Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase
PHASE2A major factor in the respiratory health of cystic fibrosis (CF) patients i...
Location
Multiple Locations
Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa
PHASE1This is a study to determine the safety and tolerability of 28 days of dail...
Location
Multiple Locations
Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)
PHASE1A major factor in the respiratory health of cystic fibrosis (CF) subjects i...
Location
Multiple Locations